Dr. Helga Grupe appointed Chief Business Officer and Managing Director of Avontec GmbH
Avontec GmbH announced that Dr. Helga Grupe was appointed Chief Business Officer and Managing Director of Avontec GmbH as of 17. September 2007.
Dr. Grupe has 16 years of experience in leadership roles in marketing and business development. She joined Avontec from Wilex AG, a publically traded German biopharmaceutical company where she served as Vice President of Business Development from 2000 to 2007. From 1996 to 2000, she held various positions with increasing responsibility in marketing and business development at Monsanto Deutschland GmbH, including Business Development Director of Europe. Prior to that, from 1995 to 1996, Dr. Grupe was Market Development Manager at Zeneca GmbH. From 1991 to 1994, she started and led the Biotechnology Co-ordination Center of the Federal State of Lower Saxony, Germany. Dr. Grupe received her PhD in biology at the University of Göttingen, Germany.
Most read news
Other news from the department people

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.